A rationally designed form of the TLR5 agonist, flagellin, supports superior immunogenicity of Influenza B globular head vaccines

201417 citationsJournal Article

Authors

Good health and well-being

Published in: Vaccine

Volume 32, Issue 34, pp. 4317-4323

Field-Weighted Citation Impact: 1.29